ACM
AlphaCrest Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-14,805
| Closed | -$968K | – | 271 |
|
|
2022
Q3 | $968K | Buy |
+14,805
| New | +$968K | 0.06% | 638 |
|
|
2022
Q1 | – | Sell |
-3,802
| Closed | -$288K | – | 1271 |
|
|
2021
Q4 | $288K | Sell |
3,802
-12,419
| -77% | -$941K | 0.01% | 1262 |
|
|
2021
Q3 | $1.82M | Buy |
+16,221
| New | +$1.82M | 0.09% | 353 |
|
|
2021
Q1 | – | Sell |
-1,400
| Closed | -$214K | – | 1203 |
|
|
2020
Q4 | $214K | Buy |
+1,400
| New | +$214K | 0.02% | 1059 |
|